Advertisement
Screener

Seelos Therapeutics, Inc. Patents: Active

Seelos Therapeutics, Inc. Active Patents

3 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-04-11: Application 18133176; Invention METHODS OF TREATING SUICIDALITY; Applicant Seelos Therapeutics, Inc.; Status Patented Case.
  • 2023-04-05: Application 18131161; Invention TREATMENT OF PROTEIN AGGREGATION MYOPATHIC AND NEURODEGENERATIVE DISEASES BY PARENTERAL ADMINISTRATION OF TREHALOSE; Applicant Seelos Therapeutics, Inc.; Status Patented Case.
  • 2022-03-30: Application 17765059; Invention TREHALOSE FORMULATIONS AND USES THEREOF; Applicant Seelos Therapeutics, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2023-04-1118133176METHODS OF TREATING SUICIDALITYSeelos Therapeutics, Inc.Patented Case2025-10-1412440457US20230241008A1
Raj Mehra
Timothy Whitaker
United States
United States
LEE, ANDREW P
2023-04-0518131161TREATMENT OF PROTEIN AGGREGATION MYOPATHIC AND NEURODEGENERATIVE DISEASES BY PARENTERAL ADMINISTRATION OF TREHALOSESeelos Therapeutics, Inc.Patented Case2025-03-0412239733US20240009113A1
Dalia Megiddo
Israel
MILLER, DALE R
2022-03-3017765059TREHALOSE FORMULATIONS AND USES THEREOFSeelos Therapeutics, Inc.Patented Case2025-07-2912370204US20220387463A1
Raj Mehra
Warren Wasiewski
Gopal Krishna
United States
United States
United States
MILLER, DALE R